Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.28M$2.28Mderived+35.6% vs Q4 2017 Net Income-$1.22M-$1.22MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$978,546N/M Operating Cash Flowderived-$582,382N/M Free Cash Flowderived-$583,221N/M Margins · derivedOperating margin-43.0%+66.1 pt vs Q4 2017
Net margin-53.5%+70.5 pt vs Q4 2017
ended Dec 31, 2018 · filed Apr 1, 2019 · 91 d after period end